GlaxoSmithKline PLC (NYSE:GSK)
| 45.51 Delayed Data As of Dec 06 |  +0.30 / +0.66%Today’s Change | 36.41 Today|||52-Week Range 46.01 | +19.10% Year-to-Date |
Latest GSK News | Press Releases
| Is Clovis Oncology Really a Buyout Candidate? Dec 03 / MotleyFool.com - Paid Partner Content | 3 Top Growth Stocks to Buy in December Dec 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 45.21 |
| Today’s open | 45.40 |
| Day’s range | 45.27 - 45.57 |
| Volume | 2,550,081 |
| Average volume (3 months) | 2,531,072 |
| Market cap | $113.5B |
Data as of 6:30pm ET, 12/06/2019
Growth & Valuation
| Earnings growth (last year) | +143.10% |
| Earnings growth (this year) | +0.96% |
| Earnings growth (next 5 years) | +4.40% |
| Revenue growth (last year) | +5.72% |
| P/E ratio | 19.0 |
| Price/Sales | 2.31 |
| Price/Book | 20.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | -0.05 | -0.11% |
| LLYEli Lilly and Co | -0.13 | -0.11% |
| NVONovo Nordisk | -0.33 | -0.58% |
| AZNAstraZeneca | +0.06 | +0.13% |
Data as of 6:30pm ET, 12/06/2019
Financials
| Next reporting date | February 5, 2020 |
| EPS forecast (this quarter) | $0.69 |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $4.8B |
| Net profit margin | 11.75% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Brentford, Greater London |
Forecasts
